Projects
International projects:
- National diabetology program – in cooperation with the Institute of Experimental Endocrinology, Slovak Academy of Sciences and University Leipzig. This is an international cooperation held under the label „SUSOD (Sorbs - Uncover the Secrets Of Disease)“ Project name: „Prevalence of diabetes mellitus in Slovak Republic – genetic screening of the population“ Duration of the study: 2007 – still in progress. (Principal coordinator in Slovakia: Prof. M. Mokáň, MD, D.Sc., FRCP Edin, co-investigator: Prof. P. Galajda, MD, PhD)
- Bilateral cooperation with Department of Diabetes, Royal Infirmary of Edinburgh, Scotland: Hypoglycaemia and driving in people with insulin treated diabetes. Duration of the project: 2007 – still in progress. (Investigators: Prof. Brian M. Frier, Prof. M. Mokáň, MD, D.Sc., FRCP Edin)
APVV Grants
• APVV-MVP-24-0252 "Modification of Gut Microbiome in Patients with Primary IgA Nephropathy." Principal Investigator: MUDr. Karol Graňák, PhD., Member of the research team: Prof. MUDr. Ivana Dedinská, PhD.
• APVV-17-0054 “New oral anticoagulants in the prevention of major cardiovascular diseases – their effects on platelets, drug interactions, safety, and use in oncology patients.” (2018 – 2022) Principal investigator: MUDr. Michal Mokáň, PhD
• APVV-14-0153 “Adipocytokine regulation in young patients with acute coronary syndrome.” (2015 – 2019) Principal investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin, Member of the research team: Prof. MUDr. Ivana Dedinská, PhD.
• APVV-0222-11 “Prediction of restenosis and stent thrombosis in patients with acute coronary syndrome following percutaneous coronary intervention.” (2012 – 2015) Principal investigator: Prof. MUDr. Peter Kubisz, DrSc., Co-investigators (1st Department of Internal Medicine): Prof. MUDr. M. Mokáň, DrSc., FRCP Edin; Prof. MUDr. P. Galajda, CSc.; MUDr. M. Samoš
VEGA research grants
• VEGA 1/0051/26 Predictors of post-transplantation diabetes mellitus (PTDM) using microRNA after kidney transplantation – PREDICT-PTDM (2026 – 2028) (Principal Investigator: prof. MUDr. Ivana Dedinská, PhD., MHA, FERA)
• VEGA 1/0168/25 “Effect of GLP1-RA treatment in patients with chronic heart failure with preserved left ventricular ejection fraction: monitoring clinical, novel molecular and imaging markers.” (2025–2027) Principal investigator: Assoc. Prof. MUDr. Tomáš Bolek, PhD
• VEGA 1/0238/21 “Continuous glucose monitoring and glycemic variability in the early post-transplant period as a predictor of complications after kidney transplantation.” (2021–2023), Principal investigators: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin / Prof. MUDr. Ivana Dedinská, PhD
• VEGA 1/0090/20 “New trends in therapy and novel markers of progression in chronic heart failure with preserved left ventricular systolic function in patients with type 2 diabetes mellitus.” (2020–2022), Principal investigator: Assoc. Prof. MUDr. Matej Samoš, PhD
• VEGA 1/0023/19 “Adipocytokines as novel markers of acute rejection in kidney transplantation.” (2019–2021), Principal investigator: Prof. MUDr. Ivana Dedinská, PhD
• VEGA 1/0160/16 “Diagnostic and prognostic value of parameters of adipocytokine regulation and glucose homeostasis in cachectic patients.” (2016–2018), Principal investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
• VEGA 1/0228/13 “Identification of markers of the obesity paradox in patients with ischemic heart disease and chronic heart failure.”(2013–2015), Principal investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
• VEGA 1/0053/11 “Metabolic and immunological aspects of cardiac cachexia, category B.” (2011–2013), Principal investigator: Prof. MUDr. P. Galajda, CSc.
• VEGA 1/0005/08 “Metabolic syndrome, adipose tissue hormones and the risk of vascular complications.” (2008–2011), Principal investigator: Prof. MUDr. P. Galajda, CSc.
• VEGA 1/4284/07 “Association of HLA class II alleles with type 1A diabetes mellitus in the Slovak population.” Investigators: Prof. MUDr. M. Mokáň, DrSc., FRCP Edin; Assoc. Prof. MUDr. J. Sadloňová, CSc.; Prof. MUDr. P. Galajda, CSc.; MUDr. D. Kantárová, PhD; RNDr. Stuchliková; MUDr. M. Kutlák; MUDr. M. Migra
• VEGA 1/1189/04 “Metabolic syndrome, subclinical inflammatory response and cardiovascular disease risk.” Co-funded by the Slovak Diabetology Society (2004–2007), Principal investigator: Prof. MUDr. P. Galajda, CSc.
• VEGA 1/8149/01 “Heterogeneity of the metabolic syndrome and disorders of hemostasis.” (2001–2003), Principal investigator: Assoc. Prof. MUDr. P. Galajda, CSc.
• VEGA 1/8155/01 “The role of nitric oxide in airway hyperreactivity.” (2001–2003), Co-investigator for the 1st Department of Internal Medicine: Assoc. Prof. MUDr. Sadloňová, CSc.
Grants of Professional Societies
• Grant of the Slovak Cardiology Society – Use of thromboelastometry in monitoring the effectiveness of antiplatelet therapy in patients with acute STEMI (2013), Principal investigator: MUDr. M. Samoš
• National Diabetology Project – Prevalence of Diabetes Mellitus in Slovakia (2003–2007), National Coordinator: Prof. MUDr. M. Mokáň, DrSc., FRCP Edin, Co-investigators: Prof. MUDr. P. Galajda, CSc.; MUDr. D. Prídavková, PhD; MUDr. Ľ. Šutarík, CSc.
Comenius University Grants (GUK)
• Excellent GUK/3034/2025 „Micro-RNA and post-transplant diabetes mellitus“ Principal Investigator: MUDr. A. Kollár
• GUK/1210/2025 - Epicardial Fat and Cardiovascular Risk in Patients with Metabolic Syndrome. Principal Investigator: MUDr. P. Lecký
• GUK/1229/2025 - Effect of GLP-1 Receptor Agonist Therapy in Patients with Heart Failure with Preserved Ejection Fraction: Evaluation of Clinical, Novel Laboratory, and Echocardiographic Parameters. Principal Investigator: MUDr. Z. Miertová
• Excellent GUK/3030/2024 – Post-translationally modified urinary fetuin-A as a marker of renal graft failure prediction. Principal investigator: MUDr. P. Kleinová
• Excellent GUK/3248/2024 – Changes in platelet aggregation in the diagnosis of acute graft rejection. Principal investigator: MUDr. T. Blichová
• GUK/143/2023 – New molecular markers in the development and progression of heart failure in obese individuals. Principal investigator: MUDr. Z. Moravčíková
• GUK/32/2023 – Impact of SCFA on changes in gut microbiota and incidence of complications in post-kidney transplantation patients. Principal investigator: MUDr. P. Kleinová
• GUK/318/2022 – Hemostasis disorders in autoimmune diseases. Principal investigator: MUDr. M. J. Péč
• GUK/240/2022 – The role of adipocytokines in the development of glomerulonephritis. Principal investigator: MUDr. M. Beliančinová
• GUK/183/2021 – Hemostasis disorders in autoimmune diseases. Principal investigator: MUDr. M. J. Péč
• GUK/302/2020 – Use of laboratory monitoring of anti-Xa activity in patients with atrial fibrillation and bleeding during treatment with xabans. Principal investigator: MUDr. K. Grilusová
• GUK/187/2020 – MicroRNA-126 as a risk marker for type 2 diabetes mellitus. Principal investigator: MUDr. J. Benko
• GUK/401/2018 – Risk of hypoglycemia in patients with diabetes mellitus treated with insulin pump therapy. Principal investigator: MUDr. V. Sváková
• GUK/386/2018 – Use of thromboelastometry in monitoring therapy with novel oral anticoagulants. Principal investigator: MUDr. B. Korpallová
• GUK/359/2018 – New risk markers for the development of type 2 diabetes mellitus. Principal investigator: MUDr. J. Benko
• GUK/18/2016 – Effect of new oral anticoagulants on platelet aggregation in patients with thromboembolic disease. Principal investigator: MUDr. M. Vnučák
• GUK/93/2016 – Metabolic syndrome and aspirin resistance. Principal investigator: MUDr. R. Michalová
• GUK/60/2014 – The role of adiponectin in the development of pulmonary embolism in patients with metabolic syndrome. Principal investigator: MUDr. S. Daruľová
• GUK/122/2013 – The role of adiponectin in the development of pulmonary embolism in patients with metabolic syndrome. Principal investigator: MUDr. S. Daruľová
• GUK/54/2012 – Use of thromboelastometry in monitoring the effectiveness of antiplatelet therapy in patients with acute STEMI. Principal investigator: MUDr. M. Samoš
• GUK/178/2012 – Acute thromboembolic disease – risk stratification and etiology in patients with metabolic syndrome. The role of thrombolytic therapy in modern treatment of pulmonary embolism. Principal investigator: MUDr. S. Daruľová
• GUK/289/2011 – Prognostic significance of serum adiponectin and leptin levels in relation to severity of coronary artery disease and heart failure in patients with the obesity paradox. Principal investigator: MUDr. M. Stančík
• GUK/47/2009 – Insulin gene polymorphism in patients with type 1 diabetes mellitus. Principal investigators: MUDr. D. Kantárová, PhD; MUDr. M. Kutlák
European Social Fund (ESF) Projects
• ESF - ITMS21+:401101B754 - Simulation Center of the Jessenius Faculty of Medicine in Martin, Comenius University Project Duration: January 2024 – December 2029Budget: EUR 9,998,159.89. Co-investigators: prof. MUDr. Ivana Dedinská, PhD.; doc. MUDr. Matej Vnučák, PhD.; MUDr. Karol Graňák, PhD.; MUDr. Martin Jozef Péč, PhD.
• ESF “Slowing the Progression of Chronic Kidney Disease by Modifying the Gut Microbiome in Patients with IgA Nephropathy”, Recovery and Resilience Plan; implementation period: 09/2024 – 05/2026.Principal investigator: Prof. MUDr. Ivana Dedinská, PhD., Co-investigators: Assoc. Prof. MUDr. Matej Vnučák, PhD., MUDr. Karol Graňák, PhD.
• ESF Operational Programme: Integrated Infrastructure (2021–2023) — project titled “Serious Civilisation Diseases and COVID-19” (Call code: OPII-VA/DP/2020/9.2-01).Co-investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
• ESF – ITMS code: 313011V344 “Long-term strategic research in the prevention, intervention, and mechanisms of obesity and its comorbidities.” Duration: 01.09.2019 – 28.02.2023 Responsible investigators (JLF UK): Prof. RNDr. Erika Halašová, PhD; Prof. MUDr. Peter Galajda, CSc.
• ESF – ITMS code: 26120230033 “Residency program for general practitioners at the Jessenius Faculty of Medicine, Comenius University in Martin.” Principal investigator: Prof. MUDr. Peter Galajda, CSc.
• ESF – ITMS code: 26220220111 “Centre of Excellence for Research in Personalized Therapy (CEVYPET).” Co-investigator (1st Department of Internal Medicine): Prof. MUDr. M. Mokáň, DrSc., FRCP Edin
• ESF – “System for comprehensive evaluation of the quality of the educational process and scientific-research activities at JLF UK in Martin.” Coordinator: Prof. MUDr. Peter Galajda, CSc.
• ESF – “Support of human resource development using the most modern methods and forms of education at JLF UK in Martin.” Co-investigator: Prof. MUDr. Peter Galajda, CSc.
• ESF – ITMS code: 26220220111 “Carcinogenic and toxic metals in the environment and workplace.” (2010–2013, Co-investigator: Assoc. Prof. MUDr. J. Sadloňová, CSc.
• ESF – “Virtual and simulation-based education as a new form of teaching at JLF UK in Martin.” Investigators: Prof. MUDr. Peter Galajda, CSc.; Assoc. Prof. MUDr. J. Sadloňová, CSc.
• ESF – “Support for innovative forms of education for students studying in the English language.” Co-investigator: Assoc. Prof. MUDr. J. Sadloňová, CSc.
Others
• Top Scientific Team “Metabolic and Hemostasis Disorders in Pregnancy” (POMEHET) — identified by the Accreditation Commission, an advisory body to the Government of the Slovak Republic, within the project announced by the Ministry of Education, Science, Research and Sport of the Slovak Republic.Principal investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin